• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用 IIb 期临床试验数据对肠易激综合征症状-便秘日记中的腹部评分进行心理测量学分析。

Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms-Constipation Using Phase IIb Clinical Trial Data.

机构信息

Outcometrix, St Petersburg, FL, USA.

Ironwood Pharmaceuticals, Inc, Boston, MA, USA.

出版信息

Value Health. 2020 Mar;23(3):362-369. doi: 10.1016/j.jval.2020.01.002. Epub 2020 Feb 20.

DOI:10.1016/j.jval.2020.01.002
PMID:32197732
Abstract

OBJECTIVES

The Diary for Irritable Bowel Syndrome Symptoms-Constipation (DIBSS-C) has been developed to assess the core signs and symptoms of irritable bowel syndrome with constipation (IBS-C). This article presents the psychometric evaluation of the DIBSS-C abdominal score.

METHODS

Data for these analyses are from a multicenter phase IIb study in IBS-C patients (NCT02559206). Subjects completed a number of assessments via handheld electronic diary throughout the study. The analyses used the intent-to-treat population and were blinded to randomized treatment group. The analyses evaluated the reliability, validity, and responsiveness of the DIBSS-C abdominal score; identified an appropriate scoring algorithm; and determined thresholds for interpreting clinically meaningful changes at the individual level.

RESULTS

The correlations between the DIBSS-C abdominal symptom items (ie, abdominal pain, discomfort, and bloating) were strong (>0.75). Cronbach's alpha for the abdominal symptom severity items was very strong (.94), indicating that the 3 abdominal symptom items produce a reliable score. The intraclass correlation coefficient for the abdominal score was 0.82, exceeding the threshold of 0.70 and indicating good test-retest reliability. Guyatt's responsiveness statistic values all exceeded the threshold for a large effect of 0.80, so the DIBSS-C abdominal score can be considered highly responsive to change. Triangulation across 3 sets of anchor-based analyses indicated that a threshold of -2.0 points on the abdominal score is an appropriate threshold for identifying meaningful change.

CONCLUSIONS

Overall, this study provides evidence that the DIBSS-C abdominal score is valid, reliable, responsive to change, and interpretable for assessing treatment benefit in patients with IBS-C.

摘要

目的

便秘型肠易激综合征症状日记(DIBSS-C)旨在评估便秘型肠易激综合征(IBS-C)的核心症状和体征。本文介绍了 DIBSS-C 腹部评分的心理计量学评估。

方法

这些分析的数据来自于 IBS-C 患者的多中心 IIb 期研究(NCT02559206)。受试者在整个研究过程中通过手持电子日记完成了多项评估。分析采用意向治疗人群,且对随机治疗组设盲。分析评估了 DIBSS-C 腹部评分的可靠性、有效性和反应性;确定了合适的评分算法;并确定了个体水平上解释有临床意义变化的阈值。

结果

DIBSS-C 腹部症状项目(即腹痛、不适和腹胀)之间的相关性很强(>0.75)。腹部症状严重程度项目的 Cronbach's alpha 非常强(.94),表明 3 个腹部症状项目产生可靠的评分。腹部评分的组内相关系数为 0.82,超过了 0.70 的阈值,表明测试-重测可靠性良好。Guyatt 的反应性统计值均超过了 0.80 的大效应阈值,因此 DIBSS-C 腹部评分可被认为对变化高度敏感。基于 3 组锚定分析的三角测量表明,腹部评分降低-2.0 分是识别有意义变化的合适阈值。

结论

总的来说,这项研究提供了证据表明,DIBSS-C 腹部评分在评估 IBS-C 患者的治疗获益方面是有效、可靠、对变化敏感且可解释的。

相似文献

1
Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms-Constipation Using Phase IIb Clinical Trial Data.使用 IIb 期临床试验数据对肠易激综合征症状-便秘日记中的腹部评分进行心理测量学分析。
Value Health. 2020 Mar;23(3):362-369. doi: 10.1016/j.jval.2020.01.002. Epub 2020 Feb 20.
2
Psychometric Evaluation of the Diary for Irritable Bowel Syndrome Symptoms-Constipation in a Prospective Observational Study.前瞻性观察研究中便秘型肠易激综合征症状日记的心理测量评估。
Value Health. 2024 May;27(5):614-622. doi: 10.1016/j.jval.2024.01.013. Epub 2024 Feb 2.
3
Psychometric validation of symptom severity measures in irritable bowel syndrome with constipation.肠易激综合征便秘症状严重程度测量的心理计量学验证。
Aliment Pharmacol Ther. 2014 Aug;40(3):298-308. doi: 10.1111/apt.12830. Epub 2014 Jun 18.
4
Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.用于评估临床试验中治疗效果的肠易激综合征症状日记的开发:基础定性研究。
Value Health. 2017 Apr;20(4):618-626. doi: 10.1016/j.jval.2016.11.001. Epub 2017 Jan 3.
5
Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation.疼痛或轻度疼痛性便秘?替代肠易激综合征便秘型与功能性便秘分类的一种有用临床方法。
Dig Dis Sci. 2018 Jul;63(7):1763-1773. doi: 10.1007/s10620-018-4995-6. Epub 2018 Feb 28.
6
How can we achieve relief of bowel and abdominal symptoms for patients with irritable bowel syndrome with constipation?对于便秘型肠易激综合征患者,我们如何缓解其肠道和腹部症状?
Expert Rev Gastroenterol Hepatol. 2013 Jul;7(5 Suppl 1):21-6. doi: 10.1586/17474124.2013.820046.
7
Psychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: a Rome Foundation report.肠易激综合征随机对照试验中患者报告结局的心理测量学评估:罗马基金会报告
Gastroenterology. 2009 Dec;137(6):1944-53.e1-3. doi: 10.1053/j.gastro.2009.08.047. Epub 2009 Aug 23.
8
Similarities and differences between IBS-C and FC with regards to symptomatology, sleep quality and psychological attributes.肠易激综合征便秘型和功能性便秘在症状、睡眠质量和心理特征方面的异同。
J Formos Med Assoc. 2020 Jan;119(1 Pt 1):75-80. doi: 10.1016/j.jfma.2019.02.017. Epub 2019 Mar 25.
9
CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis.CNCM I-3856用于肠易激综合征:一项个体受试者荟萃分析。
World J Gastroenterol. 2017 Jan 14;23(2):336-344. doi: 10.3748/wjg.v23.i2.336.
10
Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern.基于腹痛/不适严重程度和排便模式的肠易激综合征亚型。
Dig Dis Sci. 2011 Jul;56(7):2050-8. doi: 10.1007/s10620-011-1567-4. Epub 2011 Feb 3.

引用本文的文献

1
Tenapanor Improves Abdominal Symptoms Irrespective of Changes in Complete Spontaneous Bowel Movement Frequency in Adults with Irritable Bowel Syndrome with Constipation.替那帕诺可改善便秘型肠易激综合征成人患者的腹部症状,无论其完全自主排便频率有无变化。
Dig Dis. 2025;43(2):146-157. doi: 10.1159/000543166. Epub 2024 Dec 19.
2
Microbiota-derived butyrate dampens linaclotide stimulation of the guanylate cyclase C pathway in patient-derived colonoids.微生物衍生的丁酸盐可抑制源自患者的类器官中 Linaclotide 对鸟苷酸环化酶 C 通路的刺激。
Neurogastroenterol Motil. 2023 Dec;35(12):e14681. doi: 10.1111/nmo.14681. Epub 2023 Sep 22.
3
A Systematic Review of the Development and Psychometric Properties of Constipation-Related Patient-Reported Outcome Measures: Opportunities for Digital Health.
便秘相关患者报告结局指标的发展及心理测量特性的系统评价:数字健康的机遇
J Neurogastroenterol Motil. 2022 Jul 30;28(3):376-389. doi: 10.5056/jnm22004. Epub 2022 Jun 20.